Rapport Therapeutics, Inc. · NASDAQ:RAPP

Yeleswaram Krishnaswamy sold 20,225 Rapport Therapeutics, Inc. shares (Form 4)

Traded Apr 17, 2026 · Filed Apr 21, 2026

On Apr 17, 2026, Yeleswaram Krishnaswamy (Chief Development Officer) sold 20,225 Rapport Therapeutics, Inc. shares at US$39.99 for US$809K under a trading plan, leaving 246,426 shares. Filed Apr 21, 2026 (Form 4).

Sold
20,225 shares
Price
US$39.99
Value
US$809K
Holding after
246,426 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 17, 2026Common StockSale20,225US$39.99246,426Direct

Source

View original at SEC

Related